| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
1 company
Aziz Kabeer is a Director at AN2 Therapeutics, Inc.. Recent SEC Form 4 filings include 1 buy and 20 sells.
Estimated insider holdings value: $296K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 16, 2024 | ANTX An2 Therapeutics, Inc. | Director | Sell | 100,000 | $19.65 | $1,965,000.00 | -4.0% | -87.7% | -93.8% | |
| Nov 14, 2023 | ANTX An2 Therapeutics, Inc. | Director, 10% Owner | Sell | 1,810 | $16.15 | $29,224.26 | - | -68.0% | -93.7% | |
| Oct 2, 2023 | ANTX An2 Therapeutics, Inc. | Director, 10% Owner | Sell | 104,773 | $16.27 | $1,704,513.32 | -2.1% | +28.1% | -93.2% | |
| Sep 28, 2023 | ANTX An2 Therapeutics, Inc. | Director, 10% Owner | Sell | 9,357 | $16.11 | $150,707.63 | -0.2% | +31.6% | -93.4% | |
| Sep 13, 2023 | ANTX An2 Therapeutics, Inc. | Director, 10% Owner | Sell | 400 | $16.00 | $6,400.00 | - | +36.5% | -93.0% | |
| Sep 7, 2023 | ANTX An2 Therapeutics, Inc. | Director, 10% Owner | Sell | 7,140 | $16.03 | $114,484.14 | -0.1% | +24.4% | -93.4% | |
| Aug 23, 2023 | ANTX An2 Therapeutics, Inc. | Director, 10% Owner | Sell | 400 | $16.00 | $6,400.00 | - | +12.6% | -92.6% | |
| Mar 29, 2022 | ANTX An2 Therapeutics, Inc. | Director, 10% Owner | Buy | 166,666 | $15.00 | $2,499,990.00 | +8.2% | -44.1% | -34.6% |